CoChat

Intasome architecture and chromatin density modulate retroviral integration into nucleosome

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Retroviral integration depends on the interaction between intasomes, host chromatin and cellular targeting cofactors as LEDGF/p75 or BET proteins. Previous studies indicated that the retroviral integrase, by itself, may play a role in the local integration site selection within nucleosomal target DNA. We focused our study on this local association by analyzing the intrinsic properties of various retroviral intasomes to functionally accommodate different chromatin structures in the lack of other cofactors. RESULTS: Using in vitro conditions allowing the efficient catalysis of full site integration without these cofactors, we show that distinct retroviral integrases are not equally affected by chromatin compactness. Indeed, while PFV and MLV integration reactions are favored into dense and stable nucleosomes, HIV-1 and ASV concerted integration reactions are preferred into poorly dense chromatin regions of our nucleosomal acceptor templates. Predicted nucleosome occupancy around integration sites identified in infected cells suggests the presence of a nucleosome at the MLV and HIV-1 integration sites surrounded by differently dense chromatin. Further analyses of the relationships between the in vitro integration site selectivity and the structure of the inserted DNA indicate that structural constraints within intasomes could account for their ability to accommodate nucleosomal DNA and could dictate their capability to bind nucleosomes functionally in these specific chromatin contexts. CONCLUSIONS: Thus, both intasome architecture and compactness of the chromatin surrounding the targeted nucleosome appear important determinants of the retroviral integration site selectivity. This supports a mechanism involving a global targeting of the intasomes toward suitable chromatin regions followed by a local integration site selection modulated by the intrinsic structural constraints of the intasomes governing the target DNA bending and dictating their sensitivity toward suitable specific nucleosomal structures and density.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12977-015-0145-9

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 pBSK-Zeo-5S-G5E4 (p5S) acceptor plasmids used in the work. The 2.56 kb 5S-G5E4 fragment DNA for polynucleosome assembly (PN) was previously described [62] and was cloned into the pBSP-zeo vector (A). This fragment is made of two times five repeats of 5S sequences surrounding a central sequence containing five gal4 DNA binding sites and the adenovirus 2 E4 minimal promoter. The p5S vector thus contains a region 1 containing nucleosome-positioning sequences and a region 2 containing the pBSK-zeo backbone. Each 5S fragment is separated by two EcoRI restriction sites. Nucleosome occupancy prediction performed using the method previously described by [53] and used in [36] indicates the formation on the chromatinized vector of two regions with different chromatin organization (regular and stable nucleosomes in the 5S-G5E4 region 1 and less organized and stable nucleosomes in the pBSK-Zeo backbone region 2 (B). Restriction inhibition assay demonstrates that the two regions are not equally accessible since region 1 is highly protected when chromatinized whereas region 2 remains highly accessible for restriction site cutting even in the nucleosomal structure (see Additional file 1: Figure S1).
Figure 1 pBSK-Zeo-5S-G5E4 (p5S) acceptor plasmids used in the work. The 2.56 kb 5S-G5E4 fragment DNA for polynucleosome assembly (PN) was previously described [62] and was cloned into the pBSP-zeo vector (A). This fragment is made of two times five repeats of 5S sequences surrounding a central sequence containing five gal4 DNA binding sites and the adenovirus 2 E4 minimal promoter. The p5S vector thus contains a region 1 containing nucleosome-positioning sequences and a region 2 containing the pBSK-zeo backbone. Each 5S fragment is separated by two EcoRI restriction sites. Nucleosome occupancy prediction performed using the method previously described by [53] and used in [36] indicates the formation on the chromatinized vector of two regions with different chromatin organization (regular and stable nucleosomes in the 5S-G5E4 region 1 and less organized and stable nucleosomes in the pBSK-Zeo backbone region 2 (B). Restriction inhibition assay demonstrates that the two regions are not equally accessible since region 1 is highly protected when chromatinized whereas region 2 remains highly accessible for restriction site cutting even in the nucleosomal structure (see Additional file 1: Figure S1).CC BY · PubMed Central
Figure 2 HIV-1, PFV, MLV and ASV in vitro integration on naked and chromatinized p5S vectors. Concerted integration assay was performed with 10 ng of donor DNA and 100 ng of p5S naked plasmids (lanes 1), or polynucleosomal vectors assembled with increasing amounts of histones expressed as DNA/histones mass ratio (μg/μg) (1/1.1, lanes 2; 1/1.3, lanes 3) and either HIV-1, PFV, MLV (100nM) or ASV (600 nM) integrases. The reaction products were loaded onto 1% agarose gel and a representative set of experiments is shown in the figure (A). The position and structures of the donor substrate and different products obtained after half-site (HSI), full-site (FSI) and donor/donor integration (d/d) are shown. The circular FSI + HSI and linear FSI products were quantified on gel using the ImageJ software and are shown respectively in the left and right panels in (B). The circular FSI products were specifically quantified by cloning in bacteria and shown as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones as a percentage of integration reaction control performed with naked vectors (C). All the values are shown as the mean ± standard deviation (error bars) of at least three independent sets of experiments. The number of selected clones is also shown at the top of the histogram.
Figure 2 HIV-1, PFV, MLV and ASV in vitro integration on naked and chromatinized p5S vectors. Concerted integration assay was performed with 10 ng of donor DNA and 100 ng of p5S naked plasmids (lanes 1), or polynucleosomal vectors assembled with increasing amounts of histones expressed as DNA/histones mass ratio (μg/μg) (1/1.1, lanes 2; 1/1.3, lanes 3) and either HIV-1, PFV, MLV (100nM) or ASV (600 nM) integrases. The reaction products were loaded onto 1% agarose gel and a representative set of experiments is shown in the figure (A). The position and structures of the donor substrate and different products obtained after half-site (HSI), full-site (FSI) and donor/donor integration (d/d) are shown. The circular FSI + HSI and linear FSI products were quantified on gel using the ImageJ software and are shown respectively in the left and right panels in (B). The circular FSI products were specifically quantified by cloning in bacteria and shown as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones as a percentage of integration reaction control performed with naked vectors (C). All the values are shown as the mean ± standard deviation (error bars) of at least three independent sets of experiments. The number of selected clones is also shown at the top of the histogram.CC BY · PubMed Central
Figure 3 Localization of the HIV-1, PFV, MLV and ASV integration sites in both regions of the naked or chromatinized acceptor DNA. Fifty PFV, HIV-1, ASV and MLV integrants carrying the correct target DNA duplications (respectively 4, 5, 6 and 4 bp) were selected from the concerted integration shown in Figure 2 using p5S vector, either under the naked structure or chromatinized with a DNA/histones ratio of 1/1.3. The positions of the different integration events were identified and shown in region 1 or region 2. The values are plotted as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones as a percentage of integration reaction control performed with naked vectors and as the mean ± standard deviation (error bars) of at least three independent sets of experiments. The number of selected clones is also shown at the top of the histogram. A Student test was performed on serial values and the significant p values are reported in the figure.
Figure 3 Localization of the HIV-1, PFV, MLV and ASV integration sites in both regions of the naked or chromatinized acceptor DNA. Fifty PFV, HIV-1, ASV and MLV integrants carrying the correct target DNA duplications (respectively 4, 5, 6 and 4 bp) were selected from the concerted integration shown in Figure 2 using p5S vector, either under the naked structure or chromatinized with a DNA/histones ratio of 1/1.3. The positions of the different integration events were identified and shown in region 1 or region 2. The values are plotted as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones as a percentage of integration reaction control performed with naked vectors and as the mean ± standard deviation (error bars) of at least three independent sets of experiments. The number of selected clones is also shown at the top of the histogram. A Student test was performed on serial values and the significant p values are reported in the figure.CC BY · PubMed Central
Figure 4 Comparison of HIV-1, PFV, MLV and ASV integration sites and nucleosome occupanc in vitro . Fifty PFV (A), HIV-1 (B), MLV (C) and ASV (D) integrants carrying the correct target DNA duplication obtained after integration assay carried on the p5S vector chromatinized with a 1/1.3 DNA/histones ratio and localized in the 5S-G5E4 fragment were positioned onto the DNA sequence and compared to the nucleosome occupancy determined using the method previously described by [53] and used in [36].
Figure 4 Comparison of HIV-1, PFV, MLV and ASV integration sites and nucleosome occupanc in vitro . Fifty PFV (A), HIV-1 (B), MLV (C) and ASV (D) integrants carrying the correct target DNA duplication obtained after integration assay carried on the p5S vector chromatinized with a 1/1.3 DNA/histones ratio and localized in the 5S-G5E4 fragment were positioned onto the DNA sequence and compared to the nucleosome occupancy determined using the method previously described by [53] and used in [36].CC BY · PubMed Central
Figure 5 Correlation between HIV-1, PFV, MLV and ASV integration sites and nucleosome occupancy means in vitro . The mean nucleosome occupancy found at the integration site on chromatinized or naked plasmid was calculated and plotted respectively in (A) and (B). The mean nucleosome occupancy of the overall plasmid is reported as dotted line. A Student test was performed on serial values and the significant p values are reported in the figure.
Figure 5 Correlation between HIV-1, PFV, MLV and ASV integration sites and nucleosome occupancy means in vitro . The mean nucleosome occupancy found at the integration site on chromatinized or naked plasmid was calculated and plotted respectively in (A) and (B). The mean nucleosome occupancy of the overall plasmid is reported as dotted line. A Student test was performed on serial values and the significant p values are reported in the figure.CC BY · PubMed Central
Figure 6 In vitro integration catalyzed by WT and delta NED PFV INs on naked and chromatinized p5S vectors. Concerted integration assay was performed with 10 ng of donor DNA and 100 ng of p5S naked plasmids (lanes 1), or p5S polynucleosomalp5S vectors assembled with a 1/1.1 DNA/histones ratio (μg/μg) either 90nM wt PFV IN or 90nM delta NED PFV IN. The reaction products were loaded on 1% agarose gel and the linear FSI and circular FSI + HSI products were quantified on gel autoradiography using the ImageJsoftware and the values are plotted respectively in (A) and (B). The circular FSI products were specifically quantified by cloning in bacteria and plotted as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones in percentage of integration reaction control performed with naked vectors (C). The positions of the different integration events were then identified by sequencing and plotted in region 1 or region 2 (D). Values correspond to the mean ± standard deviation (error bars) of 3 independent sets of experiments. The number of selected clones is also shown at the top of the histograms. Fifty integrants carrying the correct 4 bp target DNA duplication obtained after integration assay carried on the p5S vector chromatinized with a 1/1.3 DNA/histones ratio were localized on the p5S sequence (E) and compared to the nucleosome occupancy determined using the method previously described by [53] and used in [36]. The mean nucleosome occupancy found at the integration site on chromatinized or naked plasmid was calculated and plotted respectively in (F). A Student test was performed on serial values: *p < 0.05.
Figure 6 In vitro integration catalyzed by WT and delta NED PFV INs on naked and chromatinized p5S vectors. Concerted integration assay was performed with 10 ng of donor DNA and 100 ng of p5S naked plasmids (lanes 1), or p5S polynucleosomalp5S vectors assembled with a 1/1.1 DNA/histones ratio (μg/μg) either 90nM wt PFV IN or 90nM delta NED PFV IN. The reaction products were loaded on 1% agarose gel and the linear FSI and circular FSI + HSI products were quantified on gel autoradiography using the ImageJsoftware and the values are plotted respectively in (A) and (B). The circular FSI products were specifically quantified by cloning in bacteria and plotted as the number of ampicillin-, kanamycin- and tetracycline-resistant selected clones in percentage of integration reaction control performed with naked vectors (C). The positions of the different integration events were then identified by sequencing and plotted in region 1 or region 2 (D). Values correspond to the mean ± standard deviation (error bars) of 3 independent sets of experiments. The number of selected clones is also shown at the top of the histograms. Fifty integrants carrying the correct 4 bp target DNA duplication obtained after integration assay carried on the p5S vector chromatinized with a 1/1.3 DNA/histones ratio were localized on the p5S sequence (E) and compared to the nucleosome occupancy determined using the method previously described by [53] and used in [36]. The mean nucleosome occupancy found at the integration site on chromatinized or naked plasmid was calculated and plotted respectively in (F). A Student test was performed on serial values: *p < 0.05.CC BY · PubMed Central
Figure 7 Correlation between in vivo HIV-1 and MLV integration sites positions and nucleosome occupancy. 41 435 HIV-1 integration loci obtained from [12], and 32 631 MLV integration sites obtained from [56] were plotted to human genome and submitted to the nucleosome-positioning prediction analysis set up previously [39]. The means of nucleosome occupancy surrounding the integration site (between −250 bp and 250 bp) are reported in (A). The means of nucleosome occupancy at the integration site are reported in (B) for MLV, HIV-1 and randomly generated insertion sites. The means of nucleosome occupancy in the region between −5 000 bp to + 5 000 bp from the integration site are reported in (C). Results are the means of the analyses performed from the 41435 HIV-1 and 32 361 MLV integrants. The means of nucleosomes occupancy in −1000 to 0, −500 to 0, 0 to 500 and 0 to 1000 bp regions surrounding the integration sites are reported in (D). Dotted lines represent the position of the integration sites and the global occupancy mean calculated for the entire genome.
Figure 7 Correlation between in vivo HIV-1 and MLV integration sites positions and nucleosome occupancy. 41 435 HIV-1 integration loci obtained from [12], and 32 631 MLV integration sites obtained from [56] were plotted to human genome and submitted to the nucleosome-positioning prediction analysis set up previously [39]. The means of nucleosome occupancy surrounding the integration site (between −250 bp and 250 bp) are reported in (A). The means of nucleosome occupancy at the integration site are reported in (B) for MLV, HIV-1 and randomly generated insertion sites. The means of nucleosome occupancy in the region between −5 000 bp to + 5 000 bp from the integration site are reported in (C). Results are the means of the analyses performed from the 41435 HIV-1 and 32 361 MLV integrants. The means of nucleosomes occupancy in −1000 to 0, −500 to 0, 0 to 500 and 0 to 1000 bp regions surrounding the integration sites are reported in (D). Dotted lines represent the position of the integration sites and the global occupancy mean calculated for the entire genome.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 2

  1. Brown PO. Integration. 1997.
  2. Maertens GN, Hare S, Cherepanov P. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature. 2010;468:326–9. · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Benleulmi, M. S., Matysiak, J., Henriquez, D. R., Vaillant, C., Lesbats, P., Calmels, C., Naughtin, M., Leon, O., Skalka, A. M., Ruff, M., Lavigne, M., Andreola, M.-L., & Parissi, V.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • École Normale Supérieure de Lyon (FR)
  • Fox Chase Cancer Center (US)
Corresponding author
Parissi, Vincent
Venue
Retrovirology
Published
2015-02-07
Volume
12
Issue
1
Pages
13-13
ISSN
1742-4690 (ISSN-L)
OpenAlex
W2135800359
Cited by
47
References
67
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 5
FWCI
5.27
Type
journal article
Language
en
Open access
Locations
  • Retrovirology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion, cc-by)
  • HAL (submittedVersion, other-oa)
  • Universidad de Chile (submittedVersion, cc-by-nc-nd)
  • univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
Funders
  • Cancer Research UK
  • Agence Nationale de la Recherche (ANR-11-JSV3-0006)
  • Institut National de la Santé et de la Recherche Médicale (U1016)
  • Centre National de la Recherche Scientifique (UMR8104, UMR 3569, GDR3546)
  • Universidad de Chile
  • Université de Bordeaux
  • Comisión Nacional de Investigación Científica y Tecnológica
  • National Institute of Allergy and Infectious Diseases (R01AI040385)
  • Institute of Genetics
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
retroviral integration, chromatin density, nucleosome, integration site selection, retroviral integrase, HIV-1 integrase, nucleosome occupancy, DNA bending, chromatin targeting
MeSH terms
Chromatin, DNA, Humans, Nucleosomes, Retroviridae, Virus Integration, Integrases, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intasome architecture and chromatin density modulate retroviral integration into nucleosome. https://app.cochat.ai/papers/10.1186/s12977-015-0145-9
The paper
Benleulmi, M. S., Matysiak, J., Henriquez, D. R., Vaillant, C., Lesbats, P., Calmels, C., Naughtin, M., Leon, O., Skalka, A. M., Ruff, M., Lavigne, M., Andreola, M.-L., & Parissi, V. (2015). Intasome architecture and chromatin density modulate retroviral integration into nucleosome. Retrovirology. https://doi.org/10.1186/s12977-015-0145-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.